#USA #Resonetics #Fridley #Arcline #Resolution Medical

Arcline Sells Resolution Medical to Resonetics

In a strategic move set to reshape the landscape of medical technology, Arcline Investment Management has officially announced the sale of its portfolio company, Resolution Medical, to Resonetics. This deal underscores a pivotal moment in the healthcare industry, where innovation and collaboration are essential for development.

Resolution Medical is known for its exceptional engineering services and outsourced manufacturing capabilities focused on complex Class II and III medical devices. Based in Fridley, Minnesota, the company has firmly established itself within key sectors such as structural heart, cardiology, vascular, electrophysiology, and neuromodulation therapies. With a dedicated workforce of 240 employees, more than 100 of whom are highly skilled engineers, Resolution Medical has developed a reputation for excellence in device design, prototyping, and bio-simulation through to finished product manufacturing.

Peter Herman, the Chief Executive Officer of Resolution Medical, expressed enthusiasm about the transition, saying, “With Arcline's support, Resolution Medical has become a leader in the development and commercialization of cutting-edge medical devices in the fastest-growing therapeutic modalities. We look forward to joining the Resonetics team and continuing our mission of supporting the most innovative technologies in interventional medicine to save lives and improve patient outcomes.”

Resonetics, led by CEO Kevin Kelly, recognized the potential that this acquisition brings. Kelly stated, “Resolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices. This acquisition enhances our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart, and supports our vision of becoming the most comprehensive partner in the medical device industry.”

The sale is expected to close in the first quarter of 2026, pending necessary regulatory approvals and customary closing conditions. This acquisition will allow Resonetics to expand its services and innovate further in the medical device sector, aligning with their goal to provide comprehensive solutions to meet the evolving needs of healthcare providers and patients.

Piper Sandler & Co. acted as the financial advisor for this transaction, while law firms Bass, Berry & Sims PLC and Fredrikson & Byron P.A. provided legal counsel to Resolution Medical.

About Arcline Investment Management
Arcline Investment Management is a private equity firm with a growth-oriented approach, managing assets exceeding $20 billion. The firm is dedicated to nurturing the next generation of market-leading industrial platforms designed to cultivate sustainable earnings over the long term. Their focus is not only on financial performance but also on fostering innovation across various sectors.

For additional details on this transaction and to stay updated on Resolution Medical’s future endeavors, interested parties can visit www.arcline.com.